Work has started at Cambridge Discovery Campus, a development of six laboratory-enabled buildings alongside amenity provision ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

A large portion of the jobs committed will be professional, manager, executive, and technician (PMET) roles, of which close ...

Bridgemere Land and Foundation Capital Ventures have started work at a landmark science and innovation campus to the south of ...

Jon Smith talks through the implications of the latest AI news and flags up some FTSE shares that could benefit from the ...

Dr Catherine Headley highlights how the University of Manchester Innovation Factory transforms research into real-world impact, driving progress through spinouts, collaborations, ...

Q4 2024 Earnings Call Transcript January 29, 2025 Operator: Good day. And thank you for standing by. Welcome to BXP’s Q 4 ...

The company's platform incorporates the use of patient tissues in early target and drug discovery research, building in "patient ... now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.

World’s First “Universal” Robotics Software Platform BOW Raises £4 Million Seed to Reduce Cost and Complexity of Programming ...

To ensure people benefit from high-quality care, simply training more healthcare providers and building additional ... significant breakthroughs in drug discovery, diagnostics, and treatment ...

It has emerged from the lab of Manchester medicinal chemist Professor Sam Butterworth, who has extensive drug discovery and development experience and was an inventor of AstraZeneca's blockbuster ...